MARKET

BOVNF

BOVNF

Bioinvent Intern
OTCPK
2.980
NaN%
Closed 09:30 05/23 EDT
OPEN
--
PREV CLOSE
6.63
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.980
52 WEEK LOW
2.980
MARKET CAP
196.10M
P/E (TTM)
-4.2114
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BOVNF last week (0512-0516)?
Weekly Report · 5d ago
BioInvent Reports Promising Phase 2a Results for BI-1808 in CTCL
TipRanks · 05/14 14:04
BioInvent Reports Promising Phase 2a Data for NHL Treatment
TipRanks · 05/14 14:04
Weekly Report: what happened at BOVNF last week (0505-0509)?
Weekly Report · 05/12 09:52
Weekly Report: what happened at BOVNF last week (0428-0502)?
Weekly Report · 05/05 09:53
BioInvent International AB: Q1 2025 Financial and Clinical Progress
TipRanks · 04/30 04:01
Weekly Report: what happened at BOVNF last week (0421-0425)?
Weekly Report · 04/28 09:57
Weekly Report: what happened at BOVNF last week (0414-0418)?
Weekly Report · 04/21 09:56
More
About BOVNF
BioInvent International AB is a Sweden-based biopharmaceutical company, that develops antibody-based drugs for cancer therapies, with two ongoing programs in Phase l/ll clinical trials for the treatment of haematological cancer and solid tumors. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The Company has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.

Webull offers BioInvent International AB stock information, including OTCPK: BOVNF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BOVNF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BOVNF stock methods without spending real money on the virtual paper trading platform.